OpenVSafe by OpenVAERS
Search V-safe

YP3-31051-75988

3 vaccinations 10 coded responses 38 check-ins 9 free-text entries 7 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
932 / CA
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-16
    Registered in v-safe
  2. 2021-01-16
    Dose 1 — Moderna
  3. 2021-01-16
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Redness · None
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    2 call case(s)
  7. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Headache, Joint pains
    Adult check-in
  9. 2021-01-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-30
    Survey response — day 14, dose 1
    MedDRA: Erythema, Pain in extremity — Feeling: Good
    Free text: Arm became sore again and was red in large patch.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-06
    Survey response — day 21, dose 1
    MedDRA: Chills, Headache, Nasal congestion, Pain, Pyrexia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Body aches, headache, nasal congestion, chills and fever.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-13
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-17
    Dose 2 — Moderna
  14. 2021-02-17
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Redness · Headache
    Adult check-in
  15. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Light headed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · Fatigue or tiredness
    Adult check-in
  18. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · Fatigue or tiredness
    Adult check-in
  19. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  20. 2021-02-24
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Redness · None
    Adult check-in
  21. 2021-03-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-18
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Anosmia, Headache, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Headache, body ache, fever, loss of taste and smell
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-08-18
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  29. 2021-08-24
  30. 2022-01-14
    Dose 3 — Pfizer-BioNTech
  31. 2022-01-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  32. 2022-01-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  33. 2022-01-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · Fatigue or tiredness
    Adult check-in
  34. 2022-01-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Lymph nodes in left armpit enlarged and painful.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-19
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Lymph nodes in left armpit extremely enlarged and painful.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  37. 2022-01-21
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  38. 2022-01-28
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  39. 2022-02-04
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-02-11
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-02-18
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-02-25
    Survey response — day 42, dose 3
    MedDRA: Oligomenorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Menstrual cycle is 15 days long for last 2 cycles!
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-02-25
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2022-02-28
    Call successful
    Participant prefers to complete VAERS report online
  45. 2022-04-15
    Survey response — 3 months, dose 3
    MedDRA: Heavy menstrual bleeding, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Since booster i have experienced longer and heavy menstrual bleeding. Currently on day 15 and last three have lasted 19 days on average. · Healthcare visit (other): Scheduled for hysterectomy May 2
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-04-15
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  47. 2022-04-19
  48. 2022-07-15
    Survey response — 6 months, dose 3
    MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: April 29, 2022 tested positive for COVID-19.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-07-15
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  50. 2022-07-18
  51. 2022-07-18
  52. 2022-07-18
  53. 2022-07-18
  54. 2023-01-14
    Survey response — 12 months, dose 3
    MedDRA: Sinusitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  55. 2023-01-14
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  56. 2023-01-16
  57. 2023-01-16

Vaccinations

DoseDateManufacturerCo-administered
12021-01-16Moderna
22021-02-17Moderna
32022-01-14Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-18 Successful Participant prefers to complete VAERS report online
2021-01-18 priority 2/3
2021-08-18 Successful Participant prefers to complete VAERS report online
2022-02-25 Successful
2022-02-28
Participant prefers to complete VAERS report online
2022-04-15 Unsuccessful
2022-07-15 Unsuccessful
2023-01-14 Unsuccessful

Free text

Release 3 — day 14, dose 1

2021-01-30

Symptoms: Arm became sore again and was red in large patch.

Release 3 — day 21, dose 1

2021-02-06

Symptoms: Body aches, headache, nasal congestion, chills and fever.

Release 4 — days 1–6 daily, dose 2

2021-02-18

Systemic reaction (other): Light headed

Release 9 — 6 months, dose 2

2021-08-18

Symptoms: Headache, body ache, fever, loss of taste and smell

Release 10 — days 1–6 daily, dose 3

2022-01-18

Systemic reaction (other): Lymph nodes in left armpit enlarged and painful.

2022-01-19

Systemic reaction (other): Lymph nodes in left armpit extremely enlarged and painful.

Release 11 — day 42, dose 3

2022-02-25

Symptoms: Menstrual cycle is 15 days long for last 2 cycles!

Release 11 — 3 months, dose 3

2022-04-15

Symptoms: Since booster i have experienced longer and heavy menstrual bleeding. Currently on day 15 and last three have lasted 19 days on average.
Healthcare visit (other): Scheduled for hysterectomy May 2

Release 12 — 6 months, dose 3

2022-07-15

Symptoms: April 29, 2022 tested positive for COVID-19.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAgeusia ✓ · ✓
SDAnosmia ✓ · ✓
SDChills ✓ ✓ ✓
SDErythema ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeavy menstrual bleeding · · ✓
SDNasal congestion ✓ ✓ ✓
SDOligomenorrhoea · · ✓
SDPain ✓ ✓ ✓
SDPain in extremity ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SDSinusitis · · ✓
SRODizziness ✓ ✓ ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release